Guest Blog By Arvind Mani Director of Market Access and Policy Research PDCI Market Access The pan-Canadian Pharmaceutical Alliance (pCPA) recently issued a communiqué outlining their initial perspective on subsequent entry biologics (SEBs) and innovative/reference biologics as it aims to establish a SEB policy framework. Key Takeaways It appears that the pCPA’s first principles for SEBs are targeted at ensuring that manufacturers of both SEB and
Tag: PCPA
Feds Take a Seat at the pCPA Table
Reposted with permission from the author, Arvind Mani. On January 20-21, 2016, the provincial Ministers of Health met in British Columbia to discuss health care priorities and were joined for their second day of meetings by Canada’s new federal Minister of Health, Jane Philpott. At the conclusion of their meetings, it was announced that the federal government will be joining: The pan-Canadian Pharmaceutical Alliance (pCPA) Federal/Provincial/Territorial (F/P/T) Working Group on